The use of real-time patient-reported outcomes and quality-of-life data in oncology clinical practice

Michele Y. Halyard

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The collection of patient-reported outcome (PRO) data such as quality of life (QoL) has provided important information in clinical trials. Increasingly, researchers are evaluating the use of this type of data in the clinical setting. The benefits of PRO/QoL data collection, methods for collecting data and the use of the data by clinicians are increasingly being studied. This article will address the issues and benefits of QoL and other PRO data collection within oncology clinical practice.

Original languageEnglish (US)
Pages (from-to)561-570
Number of pages10
JournalExpert Review of Pharmacoeconomics and Outcomes Research
Volume11
Issue number5
DOIs
StatePublished - Oct 2011

Fingerprint

Medical Oncology
Quality of Life
Research Personnel
Clinical Trials
Patient Reported Outcome Measures

Keywords

  • data collection
  • oncology
  • patient-reported outcomes
  • quality of life
  • symptom assessment

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Health Policy

Cite this

The use of real-time patient-reported outcomes and quality-of-life data in oncology clinical practice. / Halyard, Michele Y.

In: Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 11, No. 5, 10.2011, p. 561-570.

Research output: Contribution to journalArticle

@article{f2d434d634f6411db468505ac85d64c0,
title = "The use of real-time patient-reported outcomes and quality-of-life data in oncology clinical practice",
abstract = "The collection of patient-reported outcome (PRO) data such as quality of life (QoL) has provided important information in clinical trials. Increasingly, researchers are evaluating the use of this type of data in the clinical setting. The benefits of PRO/QoL data collection, methods for collecting data and the use of the data by clinicians are increasingly being studied. This article will address the issues and benefits of QoL and other PRO data collection within oncology clinical practice.",
keywords = "data collection, oncology, patient-reported outcomes, quality of life, symptom assessment",
author = "Halyard, {Michele Y.}",
year = "2011",
month = "10",
doi = "10.1586/erp.11.62",
language = "English (US)",
volume = "11",
pages = "561--570",
journal = "Expert Review of Pharmacoeconomics and Outcomes Research",
issn = "1473-7167",
publisher = "Expert Reviews Ltd.",
number = "5",

}

TY - JOUR

T1 - The use of real-time patient-reported outcomes and quality-of-life data in oncology clinical practice

AU - Halyard, Michele Y.

PY - 2011/10

Y1 - 2011/10

N2 - The collection of patient-reported outcome (PRO) data such as quality of life (QoL) has provided important information in clinical trials. Increasingly, researchers are evaluating the use of this type of data in the clinical setting. The benefits of PRO/QoL data collection, methods for collecting data and the use of the data by clinicians are increasingly being studied. This article will address the issues and benefits of QoL and other PRO data collection within oncology clinical practice.

AB - The collection of patient-reported outcome (PRO) data such as quality of life (QoL) has provided important information in clinical trials. Increasingly, researchers are evaluating the use of this type of data in the clinical setting. The benefits of PRO/QoL data collection, methods for collecting data and the use of the data by clinicians are increasingly being studied. This article will address the issues and benefits of QoL and other PRO data collection within oncology clinical practice.

KW - data collection

KW - oncology

KW - patient-reported outcomes

KW - quality of life

KW - symptom assessment

UR - http://www.scopus.com/inward/record.url?scp=80053479156&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053479156&partnerID=8YFLogxK

U2 - 10.1586/erp.11.62

DO - 10.1586/erp.11.62

M3 - Article

VL - 11

SP - 561

EP - 570

JO - Expert Review of Pharmacoeconomics and Outcomes Research

JF - Expert Review of Pharmacoeconomics and Outcomes Research

SN - 1473-7167

IS - 5

ER -